SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: CORRESP
Document Type: CORRESP
Date Filed: 2024-08-28
Accession Number: 0001213900-24-073422
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390024073422/filename1.htm

Chunk 0 of 1
Word Count: 330
Character Count: 2196

Document Content:

NELSON MULLINS RILEY & SCARBOROUGH LLP
ATTORNEYS AND COUNSELORS AT LAW

W. David Mannheim
david.mannheim@nelsonmullins.com 301 Hillsborough Street, Suite 1400
Raleigh, NC 27603
nelsonmullins.com

August 28, 2024

Division of Corporation Finance

U.S. Securities and Exchange
Commission

100 F Street, N.E.

Washington, DC 20549

Attention:	Tracie Mariner

Vanessa Robertson
Tamika Sheppard
Joe McCann

RE:	Synergy CHC Corp.

Amendment No. 2 to Registration Statement on Form S-1

Filed August 14, 2024

File No. 333-280556

Ladies and Gentlemen:

On behalf of Synergy CHC Corp. (the “Company”),
we are hereby responding to the letter dated August 27, 2024 (the “Comment Letter”) from the staff (the “Staff”)
of the Securities and Exchange Commission (“SEC” or the “Commission”), regarding the Company’s
Amendment No. 2 to Registration Statement on Form S-1 filed on August 14, 2024 (the “Registration Statement”). In response
to the Comment Letter and to update certain information in the Registration Statement, the Company is submitting its Amendment No. 3 to
the Registration Statement (the “Amended Registration Statement”) with the Commission today. The numbered paragraphs
below correspond to the numbered comments in the Comment Letter, and the Staff’s comments are presented in bold italics.

Amendment No. 2 to Registration Statement on Form S-1

Certain Relationships and Related Party Transactions, page 72

1.	We note your revised disclosures in response to prior
comment 6. Please revise to disclose whether there are default terms in place, including any rights and remedies in the event you do
not receive payment in full on or before the repayment date.

Response: The Company respectfully acknowledges the Staff’s
comment and advises the Staff that it has revised its disclosure on page 73 of the Amended Registration Statement.

If you have any additional questions regarding
any of our responses or the Amended Registration Statement, please do not hesitate to contact David Mannheim at (919) 329-3804.

Very truly yours,

/s/ W. David Mannheim

W. David Mannheim

cc:	Mike Bradshaw, Nelson Mullins Riley & Scarborough LLP

Jack Ross, Chief Executive Officer, Synergy CHC Corp.